NCT00508833View on ClinicalTrials.gov

Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

March 31, 2000

Conditions

Hepatitis B Disease

Interventions

BIOLOGICAL

287615 containing HBsAg with adjuvants

Trial Locations (1)

Unknown

GSK Clinical Trials Call Center, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00508833 - Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615) | Biotech Hunter | Biotech Hunter